Switch to: References

Add citations

You must login to add citations.
  1. Doing What We Can With Advance Care Planning.Benjamin H. Levi & Michael J. Green - 2010 - American Journal of Bioethics 10 (4):1-2.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Stakeholders’ Views on Early Diagnosis for Alzheimer’s Disease, Clinical Trial Participation and Amyloid PET Disclosure: A Focus Group Study.Gwendolien Vanderschaeghe, Rik Vandenberghe & Kris Dierickx - 2019 - Journal of Bioethical Inquiry 16 (1):45-59.
    Detection of Alzheimer’s disease in an early stage is receiving increasing attention for a number of reasons, such as the failure of drug trials in more advanced disease stages, the demographic evolution, the financial impact of AD, and the approval of amyloid tracers for clinical use. Five focus group interviews with stakeholders were conducted.. The verbatim transcripts were analysed via the Nvivo 11 software. Most stakeholder groups wanted to know their own amyloid PET scan result. However, differences occurred between FGs: (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations